Perceptions of Children and Young People in England on the Smokefree Generation Policy: A Focus Group Study
Nicotine and Tobacco Research · 2025
DOI: 10.1093/ntr/ntae300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Nathan P Davies und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nottingham Centre for Public Health and Epidemiology, University of Nottingham, Nottingham, UK. Hauptthemen laut MEDLINE: Smoke-Free Policy, Smoking. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Integrated Clinical Academic Programme, Department of Health and Social Care.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Modeling shows smokefree generation (SFG) policies could effectively reduce smoking rates by banning tobacco sales to those born after a specific year. Little is known about how young people perceive the legitimacy and impact of the planned SFG policy in England.
Methods
We conducted seven semi-structured focus groups with 36 participants aged 12–21 (mean = 15) in England over video call and in person. Twenty-one participants were female and 15 male. Participants were purposively sampled to include those from areas of greater deprivation and for use of tobacco or e-cigarettes. Data was analyzed using the framework approach.
Results
Participants expressed broadly negative perceptions toward tobacco and its manufacturers. Most participants supported SFG policy goals and its focus on freedom from addiction and harm; some believed it should also encompass electronic cigarettes. Many believed the law would only be successful if it included stringent enforcement, accompanying tobacco licensing, and input from young people. A minority raised concerns about the loss of freedom to purchase tobacco.
Conclusions
Communication of the freedom-giving nature of SFG is likely to resonate with many young people. Enforcement, communication, and involvement of young people in SFG should be considered carefully to maximize policy impact.
Implications
The smokefree generation (SFG) policy’s potential to offer freedom from addiction and disease can resonate with young people. Its effectiveness could be maximized through targeted enforcement in areas with high youth smoking rates and low adherence to age-of-sale laws, and through the introduction of additional policies that offer restrictive licensing of tobacco retailers. A phased approach to SFG, initially covering tobacco and later incorporating e-cigarettes as smoking prevalence declines, could balance reducing youth vaping and harm reduction; future research could investigate optimal policy conditions for this approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Nottingham Centre for Public Health and Epidemiology, University of Nottingham, Nottingham, UK.
- SPECTRUM Consortium, Edinburgh, UK.
- NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust with the University of Nottingham, Nottingham, UK.
ORCID-Profile: Nathan P Davies, Tessa Langley, Manpreet Bains
Förderung
- Integrated Clinical Academic Programme
- Department of Health and Social Care
Zitieren
APA
Davies, N. P., Murray, R. L., Langley, T., Morling, J. R., & Bains, M. (2025). Perceptions of Children and Young People in England on the Smokefree Generation Policy: A Focus Group Study. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntae300
Vancouver
Davies NP, Murray RL, Langley T, Morling JR, Bains M. Perceptions of Children and Young People in England on the Smokefree Generation Policy: A Focus Group Study. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntae300
BibTeX
@article{Davies2025,
author = {Davies, Nathan P and Murray, Rachael L and Langley, Tessa and Morling, Joanne R and Bains, Manpreet},
title = {Perceptions of Children and Young People in England on the Smokefree Generation Policy: A Focus Group Study},
journal = {Nicotine and Tobacco Research},
year = {2025},
doi = {10.1093/ntr/ntae300}
}
EUVIMED